Earlier this week, the Information Technology and Innovation Foundation (ITIF) released a report that offers a rebuttal to nine claims it identifies with the "anti-IP progressive orthodoxy." Prominent progressive senators, including Senators Bernie Sanders (D-VT) and Elizabeth Warren (D-MA), have turned up the heat on pharmaceutical companies' drug pricing and IP policies. While members of Congress on both sides of the aisle have criticized big pharma, the ITIF report identifies other "anti-IP advocates" to rebut including the Electronic Frontier Foundation (EFF), Public Knowledge, Joe Stiglitz, Dean Baker, and Arjun Jayadev. The ITIF report promotes the narrative that intellectual property rights are foundational to the United States as a nation and economy. However, the ITIF argues that anti-IP advocates are trying to persuade the Biden administration to move away from this traditional position.